Haematopoietic Stem Cell Transplantation (HSCT) in Comparison to Conventional Consolidation Therapy for Patients With Acute Myeloid Leukemia (AML) (Intermediate Risk) <= 60y. After First CR (AML)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01246752
Recruitment Status : Unknown
Verified December 2014 by University Hospital Carl Gustav Carus.
Recruitment status was:  Recruiting
First Posted : November 23, 2010
Last Update Posted : December 3, 2014
German Research Foundation
Information provided by (Responsible Party):
University Hospital Carl Gustav Carus

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : December 2017
  Estimated Study Completion Date : December 2017